Cyanogen Bromide → 5,6-difluoro-1H-1,3-benzodiazol-2-amine

HRID 9580

반응식

HRID 9580 반응식
[NH2:1][C:2]1[CH:7]=[C:6]([F:8])[C:5]([F:9])=[CH:4][C:3]=1[NH2:10].[N:11]#[C:12]Br.C(=O)(O)[O-].[Na+]>O>[F:8][C:6]1[C:5]([F:9])=[CH:4][C:3]2[NH:10][C:12]([NH2:11])=[N:1][C:2]=2[CH:7]=1

참가 물질

5

반응물 3

HCID 10476Cyanogen BromideHCID 516892Sodium BicarbonateHCID 27367551,2-Diamino-4,5-difluorobenzene

생성물 1

HCID 106787085,6-difluoro-1H-1,3-benzodiazol-2-amine수율 98.8%

시약·촉매·용매 1

HCID 962Water용매

실험 절차

The procedure used was similar to that reported in J. Med. Chem. 40:811–818, 1997. A solution of 1,2-diamino-4,5-difluorobenzene (500 mg, 3.47 mmol) in water (5 mL) was cooled to 0° C. and then treated with a solution of cyanogen bromide (0.83 mL, 4.16 mmol, 5 M in acetonitrile) and solid sodium bicarbonate (583 mg, 6.94 mmol). The solution was stirred at rt overnight and was then concentrated in vacuo. The dark residue was suspended in ethanol and heated at reflux for 15 minutes. The hot suspension was filtered, rinsing with hot ethanol, and the filtrate was concentrated in vacuo to afford 5,6-difluoro-1H-benzimidazol-2-amine (580 mg, 59%), which was used in the next step without further purification. LC-MS m/z 170.2 (MH+), ret. time 0.85 min; 1H NMR (300 MHz, DMSO-d6) δ 6.30 (br s, 2H), 7.06 (dd, 2H), 10.79 (br s, 1H).

후처리

  1. concentrationwas then concentrated in vacuo
  2. temperatureheated
  3. temperatureat reflux for 15 minutes
  4. filtrationThe hot suspension was filtered
  5. washrinsing with hot ethanol
  6. concentrationthe filtrate was concentrated in vacuo

출처 및 근거

ORD 기록
ord-d6c3407adb094fd186601245d5ddcf08
출처 데이터셋
uspto-grants-2006_08
특허 번호
US07091228B2

연결된 노트

불러오는 중…